交易 AbCellera Biologics Inc - ABCL 差價合約

交易條件

• 類型: 差價合約
• 點差: 0.05
• 長倉隔夜倉息調整: -0.02149%
• 短倉隔夜倉息調整: -0.00074%
• 隔夜倉息調整時間: 21:00 (UTC)
• 貨幣: USD
• 最低成交量: 10
• 保證金: 20.00%
• 證券交易所: United States of America
• 交易佣金: 0%
• 保證止損溢價: 1%

主要統計數據

• 前收盤價: 3.29
• 開倉: 3.4
• 1 年變化: 32.81%
• 日區間: 3.39 - 3.48

AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, AI-powered drug discovery platform searches and analyzes the database of natural immune systems to find antibodies that can be developed as drugs. The company also develops next-generation transgenic mice that provide a source of fully-human antibodies for the discovery of therapeutic antibody candidates. It has a discovery partnership agreement with Eli Lilly and Company for the discovery of various targets. AbCellera Biologics Inc. was founded in 2012 and is headquartered in Vancouver, Canada.